Advertisement

International Journal of Hematology

, Volume 73, Issue 3, pp 399–400 | Cite as

Breast Carcinoma Presenting as Immune Thrombocytopenic Purpura

  • Fadilah S.Abdul Wahid
  • Leong Chong Fun
  • Cheong Soon Keng
  • Fuad Ismail
Letter to the Editor

Keywords

Breast Carcinoma Clin Oncol Immune Thrombocytopenic Purpura Immune Thrombocytopenia Solid Tumor Malignancy 

References

  1. 1.
    Kirshner JJ, Zamkoff KW, Gottlieb AJ. Idiopathic thrombocytopenic purpura and Hodgkin’s disease: report of two cases and a review of the literature.Am J Med Sci. 1980;280:21–28.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Porrata LF, Alberts S, Hook C, et al. Idiopathic thrombocytopenic purpura associated with breast cancer: a case report and review of the current literature.Am J Clin Oncol. 1999;22:411–413.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Schwartz KA, Slichter SJ, Harker LA. Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumours.Br J Haematol. 1982;51:17–24.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bellone JD, Kunicki TJ, Aster RH. Immune thrombocytopenia associated with carcinoma.Ann Intern Med. 1983;99:470–472.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Abrahamsen AF. Effects of an enlarged splenic platelet pool in Hodgkin’s disease.Scand J Hematol. 1972;9:153–158.CrossRefGoogle Scholar
  6. 6.
    Merskey C. Pathogenesis and treatment of altered blood coagulability in patients with malignant tumors.Ann Intern Med. 1974;230:289–293.Google Scholar
  7. 7.
    Peuscher FW, Cleton FJ, Amstrong L, Stoepman-vanDalen EA, van Morik JA, vanAken WG. Significance of fibrinopeptide A (fpA) in patients with malignancy.J Lab Clin Med. 1980;96:5–14.PubMedGoogle Scholar
  8. 8.
    Kim HD, Boggs DR. A syndrome resembling immune thrombocytopenic purpura in lymphoproliferative diseases.Am J Med. 1979;67:371–377.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Garnick MB, Griffin JD. Idiopathic thrombocytopenia in association with extragonal germ cell cancer.Ann Intern Med. 1983;98:926–927CrossRefPubMedGoogle Scholar
  10. 10.
    Cummings WO, Mazur MT. Breast carcinoma diffusely metastatic to the spleen: a report of two cases presenting as idiopathic thrombocytopenic purpura.Am J Clin Oncol. 1992;97:484–489.Google Scholar
  11. 11.
    Igarashi T, Itoh K, Fuji H, et al. Successful treatment by radiation and hormone therapy of isolated local recurrence of breast cancer 24 years after mastectomy accompanied by immune thrombocytopenia: a case report.Jpn J Clin Oncol. 1998;28:270–275.CrossRefPubMedGoogle Scholar
  12. 12.
    Lissoni P, Tancini G, Paolorossi F, et al. Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study.J Pineal Res. 1999;26:169–173.CrossRefPubMedGoogle Scholar
  13. 13.
    Roubinian JR, Talal N. Neoplasia, autoimmunity and the immune response.Adv Intern Med. 1978;23:435–450.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Fadilah S.Abdul Wahid
    • 1
  • Leong Chong Fun
    • 1
  • Cheong Soon Keng
    • 1
  • Fuad Ismail
    • 2
  1. 1.Department of Hematology and Stem Cell TransplantationMalaysia
  2. 2.Department of Oncology and RadiotherapyUniversiti Kebangsaan Malaysia (UKM)Kuala LumpurMalaysia

Personalised recommendations